Shanghai Rural Commercial Bank Xin'an Li Closed-End Fund Issue 26033 (Fixed Income Enhanced) launches on March 25, with Class A shares performance benchmark of 2.1%-2.95%.

LightningPacketLoss · 2026-03-25T21:39:11+00:00

Shanghai Rural Commercial Bank has released the Xin'an Li Closed-End 26033 RMB wealth management product. The subscription period runs from March 25 to April 1, 2026, with a minimum investment of 10,000 yuan, minimum issuance scale of 10 million yuan, and maximum of 2 billion yuan. The risk level is medium-low, with a term of 750 days. The Class A performance benchmark is 2.10%-2.95%, and Class B is 2.15%-3.00%.

LightningPacketLoss

2026-03-25 21:39:11

Abstract generation in progress

On March 25, according to Shanghai Rural Commercial Bank, the Xin’an Li Closed-End 26033 Period (Fixed Income Enhancement) RMB wealth management product has a fundraising period from March 25, 2026, to April 1, 2026. The minimum subscription amount is 10,000 yuan, with a minimum issuance scale of 10 million yuan and a maximum issuance scale of 2 billion yuan. The product type is fixed income, with a medium-low risk level, and a term of 750 days. Class A shares have a performance benchmark of 2.10%-2.95% (annualized); Class B shares have a performance benchmark of 2.15%-3.00% (annualized).

Note: The performance benchmark is not the expected return, does not represent the future performance or actual returns of the product, and does not constitute a promise of product returns.

The above wealth management product information is for reference only; please refer to the “Product Prospectus” and other sales documents for specifics. This article does not constitute any investment advice. Investors operate at their own risk.

(Shanghai Rural Commercial Bank)

(Editor: Qian Xiaorui)

Keywords:

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.